InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Elliott Jeffrey Thomas, 首席财务官. Director active across 3 companies, notably Exact Sciences CORP. Cumulatively, 22 disclosures have been logged. History available since 30 April 2021. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Elliott Jeffrey Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
3,955 股Common StockSEC:0001689757-26-000005:0
23,372 股0Common StockSEC:0001689757-26-000001:0
30,534 股0Class A Common StockSEC:0000950170-25-043347:0
7,435 股0Common StockSEC:0001562180-25-000203:0
11,985 股0Common StockSEC:0001562180-24-006436:0
291 股0Common StockSEC:0000950170-24-052386:0
5,291 股0Common StockSEC:0001209191-24-004239:0
5,701 股0Common StockSEC:0001209191-24-004079:0
2,711 股0Common StockSEC:0001209191-24-003921:0
3,112 股0Common StockSEC:0001209191-24-003869:0
3,972 股0Common StockSEC:0001209191-24-003465:0
260 股@ US$47.413.3% 占其流量Common StockSEC:0001209191-23-047025:0
5,700 股0Common StockSEC:0001209191-23-014261:0
3,972 股0Common StockSEC:0001209191-23-010135:0
2,579 股0Common StockSEC:0001209191-23-009305:0
5,025 股0Common StockSEC:0001209191-22-014929:0
12,747 股0Common StockSEC:0001209191-22-013326:0
3,112 股0Common StockSEC:0001209191-22-012837:0
3,972 股@ US$78.3394.0% 占其流量Common StockSEC:0001209191-22-010409:0
3,972 股0Common StockSEC:0001209191-22-003760:0
206 股@ US$103.220.0001% mcap5.1% 占其流量Common StockSEC:0001209191-21-049201:0
206 股@ US$103.226.0% 占其流量Common StockSEC:0001209191-21-049081:0
22 条申报中的 22 条
About Elliott Jeffrey Thomas
Elliott Jeffrey Thomas is Chief Financial Officer and has 21 filings in total. In the 21 recent filings we hold, the period runs from 2021-08-02 to 2026-01-14, with Levée d'options transactions, and the largest individual amounts shown concern Exact Sciences CORP, along with filings at 0 for Quanterix Corp and Sera Prognostics, INC.
